FANCL Corp - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
FANCL Corp (FANCL) manufactures, markets, and sells cosmetics and nutritional supplements. The company's product portfolio comprises skin care products such as skin clear cleanse oil, aging products, and mild cleansing oil; and nutritional food supplements with function claims product naishi support and age bracket-based supplements, kale juice, and sundries. It also offers sundries, personnel effects, comfort undergarments, kale juice and hatsuga genmai. FANCL markets its cosmetics products under FANCL cosmetics, Mutenka, ATTENIR and bosica brands. The company sells its products through wholesale, mail order, direct stores, online and catalogue, and overseas. FANCL is headquartered in Yokohama, Kanagawa, Japan.
Scope
Detailed information on FANCL Corp required for business and competitor intelligence needs
A study of the major internal and external factors affecting FANCL Corp in the form of a SWOT analysis
An in-depth view of the business model of FANCL Corp including a breakdown and examination of key business segments
Intelligence on FANCL Corp's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about FANCL Corp, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of FANCL Corp and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess FANCL Corp as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on FANCL Corp's business structure, strategy and prospects.